If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.
Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Embellence Group | EMBELL | Apr 25, 2025 | 34.90 | -1.41 |
Embracer Group B | EMBRACB | Apr 25, 2025 | 117.82 | +1.32 |
Emilshus | EMILPREF | Apr 25, 2025 | 29.36 | +0.53 |
Emilshus B | EMILB | Apr 25, 2025 | 43.25 | -3.89 |
Enad Global 7 | EG7 | Apr 25, 2025 | 11.84 | -1.99 |
Enea | ENEA | Apr 25, 2025 | 65.40 | +1.71 |
Enersize | ENERS | Apr 25, 2025 | 0.00 | 0.00 |
Engcon AB | ENGCONB | Apr 25, 2025 | 97.90 | +3.05 |
Eniro Group | ENRO | Apr 25, 2025 | 0.41 | +1.25 |
Enorama Pharma | ERMA | Apr 25, 2025 | 3.09 | 0.00 |
Enrad | ENRAD | Apr 25, 2025 | 10.90 | +12.14 |
Envar | ENVAR | Apr 25, 2025 | 17.90 | -1.38 |
Envipco Holding | ENVIPO | Apr 25, 2025 | 58.00 | 0.00 |
Envirologic B | ENVIB | Apr 25, 2025 | 24.90 | +4.62 |
Enzymatica | ENZY | Apr 25, 2025 | 3.50 | +3.55 |
Eolus Vind B | EOLUB | Apr 25, 2025 | 50.20 | +0.90 |
Ependion AB | EPEN | Apr 25, 2025 | 138.00 | +5.67 |
Epiroc A | EPIA | Apr 25, 2025 | 206.00 | +1.43 |
Epiroc B | EPIB | Apr 25, 2025 | 182.70 | +1.50 |
Episurf Medical B | EPISB | Apr 25, 2025 | 0.12 | -0.66 |
EQL Pharma | EQL | Apr 25, 2025 | 79.00 | +0.16 |
EQT | EQT | Apr 25, 2025 | 272.50 | +1.38 |
Ericsson A | ERICA | Apr 25, 2025 | 80.20 | +1.26 |
Ericsson B | ERICB | Apr 25, 2025 | 79.88 | +0.81 |
ES Energy Save Holding | ESGRB | Apr 25, 2025 | 20.00 | -5.66 |
Essity A | ESSITYA | Apr 25, 2025 | 271.50 | 0.00 |
Essity B | ESSITYB | Apr 25, 2025 | 270.40 | -0.11 |
Eurobattery Minerals | BAT | Apr 25, 2025 | 0.06 | +11.54 |
Everysport Group AB | EVERY | Apr 25, 2025 | 19.20 | +0.52 |
Evolear AB | EVOL | Apr 25, 2025 | 1.65 | -2.94 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.